BIOPIXLAR®
Fluicell has developed Biopixlar, a game-changing bioprinting platform capable of producing tissue models by printing at the level…
WE SOLD A BIOPEN SYSTEM TO UNIVERSITY OF CAMBRIDGE
We have sold a BioPen® Prime System to University of Cambridge in UK. The BioPen® System enables researchers to…
19
Jun
2019
Welcome to new Fluicell place at Mölndal!
We are extremely happy to announce that we have just moved to bigger premises located in Mölndal. This…
06
May
2019
STERILE BIOPEN PIPETTE TIPS ARE AVAILABLE
We are pleased to announce that sterile BioPen PRIME and FLEX pipette tips are now available. From conception…
10
Apr
2019
We sold a BioPen System to Rockefeller University
We have sold a BioPen® Prime System to Rockefeller University, NYC, USA. The BioPen® System enables researchers to…
02
Apr
2019
First beta testing agreement for Biopixlar with Cellectricon
Fluicell AB today announces that the company has entered into an agreement with Cellectricon AB for beta testing…
28
Mar
2019
We are at BPS 2019 in Baltimore
So excited to be at the 63rd Annual Meeting of the Biophysical Society in Baltimore between the 2-6…
04
Mar
2019
Investigating cell stress for better health
We would like to congratulate our CTO, Gavin Jeffries for his paper “Label-free spatio-temporal monitoring of cytosolic mass,…
12
Feb
2019